Delivery Order SPE2DB20D3103-SPE2DB24FP7X7

Award Date 8/6/24
Potential Completion Date 8/7/24
Potential Value $8.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $21,547.36 firm-fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical, a major agency within the U.S. Department of Defense that procures medical supplies and equipment. The $1,225.39 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
This federal contract award is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,553.70 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,073.59 firm fixed-price contract is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a medication used in the treatment of respiratory conditions. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,742.09 firm fixed price delivery order is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, to the U.S. government. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,068.41 and is structured as a Firm Fixed Price Delivery Order, with an ultimate completion date of September 18, 2024. This award is not associated with any set-aside program....
This federal contract award is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, an essential pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical, a major military healthcare agency. The contract, valued at $8,825.81, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., a leading pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with...
This federal contract award is for the procurement of FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical products by the Defense Logistics Agency (DLA), a defense agency. The fixed-price delivery order, valued at $2,287.67, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 30, 2024 with an ultimate completion date of October 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,617.86 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The contract is not designated as a set-aside and is part of a larger...
This federal contract award is for the delivery of FLUTICASONE PROP HFA 44 MCG 10.6GM, a pharmaceutical product, to the Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,643.14, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 18, 2024, with a completion date of July 19, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation....
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP7X7
    Delivery Order

This federal contract award is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical product to the Defense Logistics Agency (DLA). The $8,793.62 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities across multiple therapeutic areas. This specific delivery order does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:20 AM